Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/1999
08/04/1999EP0932689A1 Homocysteine desulphurase from the protozoan trichomonas vaginalis
08/04/1999EP0932688A1 Chrysosporium cellulase and methods of use
08/04/1999EP0932686A2 Telomerase reverse transcriptase
08/04/1999EP0932682A1 BACILLUS THURINGIENSIS CryET29 COMPOSITIONS TOXIC TO COLEOPTERAN INSECTS AND CTENOCEPHALIDES SPP
08/04/1999EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/04/1999EP0932677A2 A gene related to migraine in man
08/04/1999EP0932675A2 Epidermal differentiation factor
08/04/1999EP0932672A1 Human sulfonylurea receptor surh
08/04/1999EP0932670A1 Evolving cellular dna uptake by recursive sequence recombination
08/04/1999EP0932667A1 Subtilase variants and compositions
08/04/1999EP0932666A1 Map kinases: polypeptides, polynucleotides and uses thereof
08/04/1999EP0932665A1 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
08/04/1999EP0932664A1 A cell-free system for initiation of dna replication
08/04/1999EP0932663A1 Moniliformin detoxification compositions and methods
08/04/1999EP0932626A1 G protein-coupled receptor antagonists
08/04/1999EP0871644A4 Platelet-endothelial cell adhesion molecule-1 compositions and methods
08/04/1999EP0840799A4 Method for the detection of viable cryptosporidium parvum oocysts
08/04/1999EP0821726A4 Multi-array, multi-specific electrochemiluminescence testing
08/04/1999EP0801688A4 Improved quantitation of gamma and x-ray emitting isotopes
08/04/1999EP0760601A4 Predicting fetal membrane rupture by mmp-9 activity
08/04/1999EP0744957B1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/04/1999EP0702729A4 Chemical process for amplifying and detecting nucleic acid sequences
08/04/1999EP0663923A4 Three highly informative microsatellite repeat polymorphic dna markers.
08/04/1999EP0642761B1 Ct system for quantitatively determining bone mineral mass
08/04/1999EP0567585B1 Hepatic growth factor receptor is the met proto-oncogene
08/04/1999EP0566633B1 Method for visually detecting the presence of a virus in a clinical specimen
08/04/1999EP0368906B2 Transcription-based nucleic acid amplification/detection systems
08/04/1999CN1225171A Direct electrochemistry of enzymes
08/04/1999CN1225134A Solid-phase activity assay for biologically active substance
08/04/1999CN1225130A Human B-cell antigens, related reagents
08/04/1999CN1225015A APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
08/04/1999CN1224761A Method for identifying compounds for inhibition of enoplastic lesions
08/03/1999US5932780 Transgenic non-human animal assay system for anti-cholinesterase substances
08/03/1999US5932779 Transgenic mouse with mutation in endogenous melanocortin-4-receptor gene; obesity, anorexia, and cachexia treatment
08/03/1999US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs.
08/03/1999US5932701 ribA
08/03/1999US5932699 Retinoid X receptor-interacting polypeptides
08/03/1999US5932694 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
08/03/1999US5932542 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof
08/03/1999US5932540 Vascular endothelial growth factor 2
08/03/1999US5932477 This novel enzyme is particularly useful for screening candidate compounds for their ability to serve as potential anti-depressant, antiasthmatic or anti-inflammatory agents.
08/03/1999US5932476 Cloning of chicken anemia virus DNA
08/03/1999US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins
08/03/1999US5932465 Phosphodiesterase 8A
08/03/1999US5932451 Method for unbiased mRNA amplification
08/03/1999US5932450 Producing chirally pure oligonucleotides using dna polymerase to synthesize chimeric oligonucleotides from template, cleaving primer extension products to separate primer and each oligonucleotide, removing template by digestion
08/03/1999US5932442 Human regulatory molecules
08/03/1999US5932441 Vectors for differential expression
08/03/1999US5932435 Screening antisense and ribozyme nucleic acids in schizosaccharomyces pombe
08/03/1999US5932434 Incubating plant tissue sample, synthase inhibitor, and keto acid reductoisomerase inhibitor in aqueous medium; detecting accumulation of acetolactate; for detection of herbicide resistance
08/03/1999US5932432 Expression library screen by prenylation of expressed proteins
08/03/1999US5932429 Methods of diagnosing clinical subtypes of crohn's disease
08/03/1999US5932425 Compositions and methods for modulating cellular NF-κB activation
08/03/1999US5932423 Cyclic nucleotide phosphodiesterases
08/03/1999US5932419 Annealing mutagenic primers which are complementary to each other to each strand of circular double-stranded dna, synthesizing mutant dna by linear cyclic amplification, forming circular mutant dna, digesting parent strands
08/03/1999US5932418 Testing for cytological damage or apoptosis; exposing transparent embryos to aqueous chemical solutions, electromagnetic waves or radiation; fixing and staining embryos; optically analyzing for presence of label
08/03/1999US5932416 Method for detecting the presence of RNA belonging to an organ or tissue cell-type
08/03/1999US5932415 Processes and agents for detecting listerias
08/03/1999US5932414 Methods and compositions for the monitoring and quantitation of minimal residual disease in hematopoietic tumors
08/03/1999US5932413 DNA probe assay using neutrally charged probe strands
08/03/1999US5932410 Assay for the detection of proteases
08/03/1999US5932219 Polypeptides
08/03/1999US5932212 Crosslinked protein crystal formulations and their use as catalysts in organic solvents
08/03/1999US5932173 Quality control for biological decontamination and sterilization
07/1999
07/30/1999CA2246001A1 Novel compounds
07/29/1999WO1999038014A1 Assessing risk for integrin antagonist/agonist mediated diseases
07/29/1999WO1999038010A1 PAI-2 AND t-PA AS DIAGNOSTIC MARKERS OF PERIODONTAL DISEASE
07/29/1999WO1999038008A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
07/29/1999WO1999038003A1 Microfabricated aperture-based sensor
07/29/1999WO1999037986A2 Androgen-metabolic gene mutations and prostate cancer risk
07/29/1999WO1999037821A1 Methods and compositions to investigate infection by hepatitis b virus and agents to prevent and treat the infection
07/29/1999WO1999037820A1 An exponential nucleic acid amplification method using a single primer of opposing polarity
07/29/1999WO1999037819A2 Amplification of nucleic acids with electronic detection
07/29/1999WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor
07/29/1999WO1999037817A1 Gene expression methods for screening compounds
07/29/1999WO1999037816A1 Methods for identifying therapeutic targets
07/29/1999WO1999037815A1 ISOTHERMAL TRANSCRIPTION BASED ASSAY FOR THE DETECTION AND QUANTIFICATION OF CHEMOKINE RANTES, MIP-1α AND MIP-1$g(b)
07/29/1999WO1999037814A1 Microparticles with multiple fluorescent signals
07/29/1999WO1999037813A1 Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids
07/29/1999WO1999037812A1 Single nucleotide polymorphisms of the uncoupling protein 2 (ucp2) gene
07/29/1999WO1999037811A1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease
07/29/1999WO1999037810A1 A method, reagent solution and kits for dna sequencing
07/29/1999WO1999037809A1 Asthma related genes
07/29/1999WO1999037808A1 Method for dna sequencing
07/29/1999WO1999037807A1 Method of isolation of rna-binding compounds
07/29/1999WO1999037806A2 Modified nucleic acid probes and uses thereof
07/29/1999WO1999037805A1 Method for detection of nucleic acid target sequences involving in vitro transcription from an rna promoter
07/29/1999WO1999037804A2 EF-Tu mRNA AS A MARKER FOR VIABILITY OF BACTERIA
07/29/1999WO1999037803A2 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
07/29/1999WO1999037802A1 Methods to identify myelostimulants
07/29/1999WO1999037801A1 Testing beta-thalassaemic status using substrates for pyrimidine 5'-nucleotidase
07/29/1999WO1999037800A1 Antimicrobial compounds
07/29/1999WO1999037799A1 Antibiotic sensitivity testing
07/29/1999WO1999037797A1 Antigen-specific cells, methods of generating these cells and uses thereof
07/29/1999WO1999037790A1 Human calcineurin b-like protein
07/29/1999WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/29/1999WO1999037783A2 Live vaccine against brucellosis
07/29/1999WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications
07/29/1999WO1999037765A1 Human vanilloid receptor homologues
07/29/1999WO1999037763A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype